Koelis and Bot Image Partner to Enhance Prostate Cancer Detection with AI-Powered Fusion Biopsy Technology
Koelis has announced a strategic partnership with Bot Image to integrate ProstatID™, an FDA-cleared AI-based lesion detection software, with their Trinity® MRI-fusion guidance system for improved prostate cancer diagnostics.
VIOLETTE Trial Shows Promise for Precise Microwave Ablation in Prostate Cancer
Interim results from the VIOLETTE trial indicate that organ-based tracking fusion (OBT-Fusion) technology allows for precise planning in targeted microwave ablation of prostate cancer.
KOELIS Announces Positive Interim Results from VIOLETTE Trial on Targeted Microwave Ablation for Prostate Cancer
The VIOLETTE trial, a multicenter Phase II study, evaluates KOELIS' OBT-Fusion technology for targeted microwave ablation (TMA) in prostate cancer.
© Copyright 2025. All Rights Reserved by MedPath